Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 7, 2005, Pages 3011-3013

  Reinert, Ralf René ^a,b   Al Lahham, Adnan ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MACROLIDE; PROTEIN L22; PROTEIN L4; RIBOSOME PROTEIN; RNA 23S; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; GENE MUTATION; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RNA GENE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; TIME;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTATION; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 21444459546     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.7.3011-3013.2005     Document Type: Article

References (14)

1. Abbanat, D., G. Webb, B. Foleno, Y. Li, M. Macielag, D. Montenegro, E. Wira, and K. Bush. 2005. In vitro activities of novel 2-fluoro-naphthyridine- containing ketolides. Antimicrob. Agents Chemother. 49:309-315.
2. Hyde, T. B., K. Gay, D. S. Stephens, D. J. Vugia, M. Pass, S. Johnson, N. L. Barrett, W. Schaffner, P. R. Cieslak, P. S. Maupin, E. R. Zell, J. H. Jorgensen, R. R. Facklam, and C. G. Whitney. 2001. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286:1857-1862.
3. Musher, D. M., M. E. Dowell, V. D. Shortridge, R. K. Flamm, J. H. Jorgensen, P. Le Magueres, and K. L. Krause. 2002. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:630-631.
4. Nagai, K., P. C. Appelbaum, T. A. Davies, L. M. Kelly, D. B. Hoellman, A. T. Andrasevic, L. Drukalska, W. Hryniewicz, M. R. Jacobs, J. Kolman, J. Miciuleviciene, M. Pana, L. Setchanova, M. K. Thege, H. Hupkova, J. Trupl, and P. Urbaskova. 2002. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries. Antimicrob. Agents Chemother. 46:371-377.
5. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing. Supplement M100-S14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. Onega, M., F. Marco, M. Almela, J. Puig, A. Soriano, and J. Mensa. 2004. Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections. Int. J. Antimicrob. Agents 24:616-618.
7. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1996. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother. 40:2071-2074.
8. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1994. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrob. Agents Chemother. 38:2065-2072.
9. Reinert, R. R. 2004. Clinical efficacy of ketolides in the treatment of respiratory tract infections. J. Antimicrob. Chemother. 53:918-927.
10. Reinert, R. R., A. Al-Lahham, M. Lemperle, C. Tenholte, C. Briefs, S. Haupts, H. H. Gerards, and R. Lütticken. 2002. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J. Antimicrob. Chemother. 49:61-68.
11. Reinert, R. R., R. Lütticken, A. Bryskier, and A. Al-Lahham. 2003. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob. Agents Chemother. 47:489-493.
12. Reinert, R. R., A. Wild, P. Appelbaum, R. Lütticken, M. Y. Cil, and A. Al-Lahham. 2003. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob. Agents Chemother. 47:2319-2322.
13. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
14. Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.